Close Menu

More articles about Clinical Lab Management

While serology has been little used throughout the pandemic, the vaccine rollout presents new opportunities both for research and clinical use.

The drugstore will sell Pixel by Labcorp kits in up to 6,000 stores, with the goal of providing a testing option at stores that don't currently have on-site testing.

Laboratory staffing and supply shortages limited patient access to cancer screening tests, and the pandemic decreased the development and validation of new tests.

In a recent commentary, the officials recounted the various factors that led to a troubled rollout of SARS-CoV-2 serology testing this spring.

A pair of studies published this week present an analysis of a real, large-scale testing pooling effort as well as analyses of how to further improve such strategies.

The expanded partnership includes a commercial agreement for the ClonoSeq and ImmunoSeq assays, as well as a lab service agreement for the T-Detect COVID test.

The lab will use its phlebotomy network to help Grail with specimen collection for its Galleri multi-cancer early detection blood test, slated to launch this year.

The company has performed 100,000 rapid tests for SARS-CoV-2 to date for a variety of organizations, including sports leagues and public schools.

TruGenX claims that Thermo Fisher's technical support did not resolve testing issues for months, damaging its business and reputation.

In one of the first projects to study large-scale antigen testing, the assays detected a significant number of cases but had little apparent effect on overall rates.

The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance.

The administration will expand COVID-19 testing for schools and underserved populations, increase manufacturing of testing supplies, and increase genomic sequencing.

LifeLabs and Multiplex Genomics, a University of Guelph spinout, will work together to provide SARS-CoV-2 testing in Canada and track variants of the virus.

The organization also supported the recommendation to include $1.75 billion in funding for the US Centers for Disease Control and Prevention.

Revenues were $4.49 billion, up from $2.95 billion in the same quarter last year and beating analysts' average estimate of $3.95 billion.

Newly emerged strains present considerations for labs ranging from concerns around test effectiveness to regulatory and reimbursement questions.

The company believes reimbursement pressures and trends toward tighter insurance networks will continue to provide it with lab acquisition targets.

The healthcare company and its subsidiary allegedly ordered residents of a residential treatment center to undergo unnecessary drug screenings multiple times a week.

Revenue was $3.00 billion, up from $1.93 billion in the same quarter last year and above the consensus Wall Street estimate of $2.93 billion.

MedTest's subsidiaries have particular expertise in FDA 510(k) and CLIA clearances, which will help Horiba address the needs of customers.